Erin K. Brenner

Insider Reports History

Entity
Individual
Location
C/O Pear Therapeutics, Inc., 200 State Street, 13 Th Floor, Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin K. Brenner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Chief Product Dev. Officer Restricted Stock Units 952K Feb 15, 2023 Direct
Pear Therapeutics, Inc. Chief Product Dev. Officer Stock Option (Right to Buy) 90.2K Dec 9, 2022 Direct
Pear Therapeutics, Inc. Chief Product Dev. Officer Common Stock 52K Jan 14, 2023 Direct
Pear Therapeutics, Inc. Chief Product Dev. Officer Class A Common Stock 43.3K Jan 20, 2023 Direct

Insider Reports Filed by Erin K. Brenner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEARQ Pear Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. Jan 20, 2023 1 -$9.82K 4 Jan 24, 2023 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. Jan 14, 2023 2 $0 4 Jan 18, 2023 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. Dec 9, 2022 2 $15K 4 Dec 9, 2022 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. May 25, 2022 2 $15K 4 May 27, 2022 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. Feb 16, 2022 2 $0 4 Feb 18, 2022 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 6 $0 4 Dec 7, 2021 Chief Product Dev. Officer
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Chief Product Dev. Officer